Intalight™ Receives CE Mark for Innovative DREAM OCT™ Imaging System

In a remarkable achievement for the field of ophthalmology, Intalight™, a leading developer of advanced ophthalmic technologies, has been awarded the CE mark for its innovative imaging system, DREAM OCT™. This system represents the latest advancement in Optical Coherence Tomography (OCT) imaging, signifying a major step forward in eye care technology aimed at delivering superior diagnostic results to eye care specialists across Europe.

The CE mark is a crucial certification that allows products to be marketed in the European Economic Area, showcasing compliance with safety and health standards. The DREAM OCT™ system is set to revolutionize eye imaging with enhanced features that set it apart from its competitors. The acronym DREAM signifies its key capabilities: Deep imaging depth, Rapid scan speed, Extensive scanning range, Accurate results, and Multimodal imaging capabilities.

Cutting-Edge Imaging with DREAM OCT™



DREAM OCT™ surpasses prior technology with its ultra-wide-field scanning capability that produces a single OCTA image covering an impressive 130-degree field. This broad scope aims to capture important details of the eye, providing a more comprehensive view than ever before. Additionally, the system facilitates a super depth scan measuring 12 mm, allowing unparalleled imaging of the choroid, retina, and a significant portion of the vitreous space. The anterior scanning dimension extends up to 16.2 mm in air, effectively capturing the entire anterior segment in one single scan, ultimately leading to quicker and more effective diagnoses.

Shawn Peng, President and Founder of Intalight, expressed his pride in achieving this milestone. “Receiving the CE mark is a testament to our dedication to providing eye care professionals with state-of-the-art technology that greatly improves patient outcomes,” he stated. This approval now permits the distribution of the revolutionary DREAM OCT™ to ophthalmologists throughout Europe, enhancing their diagnostic capabilities significantly.

Meeting the Needs of Vision Professionals



According to Bing Li, the CEO and co-founder of Intalight, the feedback from eye care professionals in recent years highlighted the need for a high-performing imaging solution capable of addressing their challenges in speed, accuracy, and depth of analysis. The DREAM OCT™ meets these demands effectively, offering a full suite of imaging modalities for the most complex clinical and research applications concerning retinal health. With over 160 peer-reviewed articles utilizing data from this state-of-the-art device, its reliability and effectiveness in practice are well-established.

Intalight’s leadership in ultra-wide-field OCT imaging technology has established partnerships with leading retina academic institutions and private practices across the United States, Europe, and Asia. The company looks forward to leveraging its recent CE approval to expand its prestigious network of global institutions and ophthalmologists.

Future Prospects in Eye Care Technology



The excitement surrounding the CE mark for DREAM OCT™ is palpable within the company. Joe Garibaldi, Vice President of Sales at Intalight, remarked, “This is fantastic news and we cannot wait to bring such innovative solutions to our customers in the United States in the near future.” Additionally, the company is actively working toward gaining FDA approval, which would allow even wider access to this revolutionary technology within the American healthcare system.

With state-of-the-art features and design, Intalight’s DREAM OCT™ is not just intended for everyday clinical usage; it also serves as a significant tool for research, pushing the boundaries of what is possible in ophthalmic technology. As the need for innovative diagnostic tools grows, Intalight is committed to remaining at the forefront, ensuring that both healthcare professionals and patients can benefit from cutting-edge solutions in eye care.

For more details on Intalight and its groundbreaking DREAM OCT™ system, please visit Intalight's Official Website and follow them on LinkedIn and Facebook for updates.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.